Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12609000912280
Ethics application status
Approved
Date submitted
16/10/2009
Date registered
21/10/2009
Date last updated
1/09/2024
Date data sharing statement initially provided
1/09/2024
Date results provided
1/09/2024
Type of registration
Retrospectively registered

Titles & IDs
Public title
INCITE - a randomised trial of Novel upper limb rehabilitation in congenital hemiplegia
Scientific title
"A Randomised Trial Comparing Constraint Induced Movement Therapy and Bimanual Training on Upper Limb Function in Patients with Congenital Hemiplegia ".
Secondary ID [1] 1117 0
Nationa Health and Medical Research Council (NHMRC) 368500
Universal Trial Number (UTN)
Nil
Trial acronym
INCITE
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Congenital Hemiplegia 252018 0
Cerebral Palsy 252019 0
Condition category
Condition code
Neurological 252212 252212 0 0
Other neurological disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Constraint Induced movement therapy involves use of tailor made glove like splint worn on the unimpaired (dominant writting hand) and intensive activity based practice activities encouraging active use and manipulation with the other impaired (hemiplegic hand). Participants in the CIMT group will wear a tailor made glove on their unimpaired limb while attending the day camp, which will only be removed for toileting. The training occurs for 6 hours per day over 10 days for a total dose of 60 hours, with one trainer per two participants, in a comunity recreation facility.
Intervention code [1] 241421 0
Rehabilitation
Comparator / control treatment
Bimanual Training involves atcivity based practice with tasks that focus on equal use of both hands (both the unimpaired and the hemiplegic hand) in the task. The training occurs for 6 hours per day over 10 days for a total dose of 60 hours, with one trainer per two participants, in a comunity recreation facility.
Control group
Active

Outcomes
Primary outcome [1] 253081 0
Unimanual capacity for the hemiplegic limb measured on the Melbourne Unilateral Upper Limb Assessment
Timepoint [1] 253081 0
at 26 weeks post intervention
Secondary outcome [1] 257931 0
Bimanual Co-ordination on the Assisting Hand Assessment (AHA)
Timepoint [1] 257931 0
at 26 weeks post
Secondary outcome [2] 257932 0
Neuroplasticity determined on the Motor Evoked Potential (MEP) curves using Transcranial Magnetic Stimulation (TMS)
Timepoint [2] 257932 0
at 26 weeks post intervention
Secondary outcome [3] 257933 0
Community participation across borad domians on the Life Habits Questionnaire.
Timepoint [3] 257933 0
at 26 weeks post intervention
Secondary outcome [4] 257934 0
Quality of Life on the Cerebral Palsy Quality of Life Quesstionnaire (the CPQOL-Child Questionnaire).
Timepoint [4] 257934 0
at 26 weeks post intervetnion
Secondary outcome [5] 257935 0
Neurovascular changes in the primary motor cortex
Timepoint [5] 257935 0
at 26 weeks post intervention

Eligibility
Key inclusion criteria
Inclusion criteria
The study will include children and youth:
1. With a confirmed diagnosis of congenital hemiplegia.
2. Aged 5 to 16 years.
3. With predominant spasticity rather than dystonia interfering with upper limb function according to the classification of motor type by Sanger et al[31] with Modified Ashworth Scale grade >1 but <3.[32]
4. Ability to achieve minimal active grasp with the impaired hand.
5. Sufficient co-operation and cognitive understanding to participate in the group activities.
For a subset of children performing the Advanced Brain Imaging and Transcranial Magnetic Stimulation (TMS) studies further inclusion criteria are:-
1. Sufficient co-operation to perform Advanced Brain Imaging studies for 45 minutes.
2. No exclusions for 3 tesla Magnetic Resonance Imaging (3T MRI) including no metal implants, no shunts, no uncontrolled epilepsy as the later would be a confound.
3. For TMS there must be no current or previous history of epilepsy.
Minimum age
5 Years
Maximum age
16 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Severe muscle spasticity and/or contracture on the Modified Ashworth Scale(MAS > grade 3, i.e. muscle contracture or rigidity) which would require spasticity management or serial casting.
2. Previous orthopaedic surgery in the upper limb.
3. Serial casting or Botulinum Toxin A (BoNT-A) injections in the upper limb within 6 months prior to study entry.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Children will be matched in pairs according to age (12 month age bands), gender, side of hemiplegia, and level of functional ability based on Melbourne Unilateral Upper limb Assessment (MUUL) scores at screening. Once matching has been achieved and baseline assessments completed, children will be randomised within pairs from concealed envelopes opened by non-study personnel. Treatment allocation will be recorded on a piece of folded paper inside each envelope in random order (computer generated). The randomisation process will involve allocating a number “1” or “2’ to each member of the pair which will be written on the paper inside the envelope. As each pair is entered, they will be allocated the next consecutive envelope, which will be opened by the non-study personnel who will read and record the treatment allocation from the paper inside the envelope. Study personnel will be informed of group allocation.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
randomisation within pairs by computer number generation of 0 or 1 alternatives within the pairs
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Nil
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/04/2007
Actual
1/06/2007
Date of last participant enrolment
Anticipated
Actual
1/06/2010
Date of last data collection
Anticipated
Actual
9/07/2010
Sample size
Target
52
Accrual to date
Final
64
Recruitment in Australia
Recruitment state(s)
QLD,VIC

Funding & Sponsors
Funding source category [1] 243890 0
Government body
Name [1] 243890 0
National Health and Medical Research Institute
Country [1] 243890 0
Australia
Primary sponsor type
Government body
Name
National Health and Medical Research Insitute
Address
National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601
Country
Australia
Secondary sponsor category [1] 251235 0
Charities/Societies/Foundations
Name [1] 251235 0
Royal Childrens Hospital Foundation
Address [1] 251235 0
Royal Childrens Hospital Foundation,
Royal Childrens Hospital,
Herston rd.,
Herston. 4006
Country [1] 251235 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 244005 0
Royal Children?s Hospital and Health Services District
Ethics committee address [1] 244005 0
Ethics committee country [1] 244005 0
Australia
Date submitted for ethics approval [1] 244005 0
31/05/2008
Approval date [1] 244005 0
01/07/2008
Ethics approval number [1] 244005 0
HREC 2008/018
Ethics committee name [2] 244006 0
Royal Childrens Hospital, Melbourne
Ethics committee address [2] 244006 0
Ethics committee country [2] 244006 0
Australia
Date submitted for ethics approval [2] 244006 0
01/02/2007
Approval date [2] 244006 0
01/03/2007
Ethics approval number [2] 244006 0
HREC 26074 A,B,C,D
Ethics committee name [3] 244007 0
University of Queensland
Ethics committee address [3] 244007 0
Ethics committee country [3] 244007 0
Australia
Date submitted for ethics approval [3] 244007 0
01/07/2008
Approval date [3] 244007 0
01/08/2008
Ethics approval number [3] 244007 0
2008000961

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 30393 0
Prof Roslyn Boyd
Address 30393 0
Queensland Cerebral Palsy and Rehabilitation Research Centre

Child Health Research Centre
The University of Queensland
Centre for Children’s Health Research
Room 611, Level 6, 62 Graham Street
South Brisbane QLD 4101 Australia
Country 30393 0
Australia
Phone 30393 0
+61 7 30697372
Fax 30393 0
+61 7 30697109
Email 30393 0
r.boyd@uq.edu.au
Contact person for public queries
Name 13640 0
Roslyn Boyd
Address 13640 0
Queensland Cerebral Palsy and Rehabilitation Research Centre

Child Health Research Centre
The University of Queensland
Centre for Children’s Health Research
Room 611, Level 6, 62 Graham Street
South Brisbane QLD 4101 Australia
Country 13640 0
Australia
Phone 13640 0
+61 7 30697372
Fax 13640 0
+61 7 30697109
Email 13640 0
r.boyd@uq.edu.au
Contact person for scientific queries
Name 4568 0
Roslyn Boyd
Address 4568 0
Queensland Cerebral Palsy and Rehabilitation Research Centre

Child Health Research Centre
The University of Queensland
Centre for Children’s Health Research
Room 611, Level 6, 62 Graham Street
South Brisbane QLD 4101 Australia
Country 4568 0
Australia
Phone 4568 0
+61 7 30697372
Fax 4568 0
+61 7 30697109
Email 4568 0
r.boyd@uq.edu.au;

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
Data sharing will follow the UQ Guidelines. Only deidentified data and outcomes will be shared.


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.